Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Rhabdoid Tumor × Panobinostat × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 4 Diffuse Intrinsic Pontine Glioma 3 Brain Neoplasms 2 Rhabdoid Tumor 1 Recurrence 1 Oligodendroglioma 1 Neoplasms 1 Meningioma 1 Gliosarcoma 1 Glioblastoma 1 Astrocytoma 1

Interventions

Cyclophosphamide 11 Etoposide 8 X-Rays 6 Temozolomide 6 Phantoms, Imaging 6 Magnetic Resonance Spectroscopy 6 Granulocyte Colony-Stimulating Factor 6 Carboplatin 6 etoposide phosphate 5 Thiotepa 5 Specimen Handling 5 Nuclear Medicine Department, Hospital 5 Filgrastim 5 fludarabine 4 Topotecan 4 Stem Cell Transplantation 4 Radiotherapy 4 Melphalan 4 Biopsy 4 palbociclib 3 Vincristine 3 Sirolimus 3 Peripheral Blood Stem Cell Transplantation 3 Methotrexate 3 Mesna 3 Ifosfamide 3 Cisplatin 3 Busulfan 3 Automobiles 3 ulixertinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04897880 2025-02-24

NORTH

Australian & New Zealand Children's Haematology/Oncology Group

Phase 2 Terminated

Brain Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡